Dr. Rose recently contributed a chapter to a comprehensive book on the subject entitled Chemotherapy Induced Neuropathic Pain.
Online PR News – 05-September-2012 – NJ – Neptune, NJ - Since 2003, Michael Rose, M.D., has helped develop and advance surgical treatment options for neuropathy, a chronic condition that results from damage to or compression of the nerves outside the spinal cord, often as a result of chemotherapy. Based on his groundbreaking work, Dr. Rose recently contributed a chapter to a comprehensive book on the subject entitled Chemotherapy Induced Neuropathic Pain.
In Chemotherapy Induced Neuropathic Pain, Dr. Rose explores surgical options for neuropathy, and explains the treatment for a debilitating condition that is becoming more widespread with the increase in cancer therapies. Written for pain management specialists, oncologists, pharmacologists, students, and primary care practitioners, Chemotherapy Induced Neuropathic Pain offers insight into the normal physiology of pain transmission pathways, neuropathic pain pathology, the chemotherapeutic drug mechanisms of action and adverse effects, chemotherapy-induced neuropathy, and drug discovery efforts for treatment.
Nearly 20 million Americans suffer from neuropathy, which can be caused by chemotherapy, traumatic injury, lead poisoning, alcoholism and diabetes. Diabetes is the most common cause of neuropathy, but in many cases, neuropathy occurs spontaneously and seemingly without cause. Also referred to as peripheral neuropathy, the disorder can manifest in different forms—as mononeuropathy when only one nerve is affected, and as polyneuropathy when many nerves are involved, often symmetrically on both sides of the body. With neuropathy, there is decreased sensation, numbness or tingling in the extremities serviced by these nerves. This loss of feeling can lead to wounds that don’t heal, infection and even amputation.
Fortunately, in select cases neuropathy can be improved or reversed with nerve decompression surgery. Performed on an outpatient basis and taking less than an hour, the procedure involves relieving the pressure on a nerve by surgically removing the constricting tissue or bone, or widening the canal encasing the nerve. Decompression surgery is successful in relieving the symptoms of neuropathy in up to 90% of well selected patients. The procedure is minimally invasive, requiring only small incisions over the affected area, promoting a quicker recovery. Dr. Rose, along with his colleagues at the Center for Treatment of Paralysis and Reconstructive Nerve Surgery, are among the fewer than twenty plastic surgeons in the world that have been specifically trained in this surgery.
About the Center for Treatment of Paralysis and Reconstructive Nerve Surgery:
Located at Jersey Shore University Medical Center in Neptune, New Jersey, the Center for Treatment of Paralysis and Reconstructive Nerve Surgery is one of the first comprehensive centers of its kind, uniquely combining advanced surgical treatments for paralysis and nerve damage, with rehabilitation, continuum of care and research. The center’s world renowned specialists, including Andrew Elkwood, M.D., Michael Rose, M.D., Matthew Kaufman, M.D., Tushar Patel, M.D., Russell Ashinoff M.D., are dedicated to providing innovative surgical treatment and restoring hope to those affected by paralysis and nerve injury.
About Jersey Shore University Medical Center:
Jersey Shore University Medical Center, a member of the Meridian Health family, is a not-for-profit teaching hospital and home to K. Hovnanian Children’s Hospital – the first children’s hospital in Monmouth and Ocean counties. Jersey Shore is the regional provider of cardiac surgery, a program which has been ranked among the best in the Northeast, and is home to the only trauma center and stroke rescue center in the region. Jersey Shore University Medical Center specializes in cardiovascular care, orthopedics and rehabilitation, cancer care, neuroscience, and women’s specialty services. For more information on Jersey Shore University Medical Center call 1-800-560-9990, or visit www.JerseyShoreUniversityMedicalCenter.com.
Maureen Gillespie, Manager, Public Relations